相似化合物
627-18-9 4457-67-4 58929-72-9欧盟法规
ECHA物质C&L通报REACH预注册上下游产品
CAS号1589-49-7 3-甲氧基-1-丙醇 | CAS号186581-53-3 重氮甲烷 | CAS号627-18-9 3-溴-1-丙醇 | CAS号420-37-1 三甲基氧鎓四氟硼酸 | CAS号67-56-1 甲醇 | CAS号109-64-8 1,3-二溴丙烷 | CAS号124-41-4 甲醇钠 | CAS号10513-96-9 1H-Isoindole-1,... | CAS号111088-69-8 (3-甲氧基丙基)三苯基溴化膦 | CAS号1079402-67-7 1-溴-2-(3-甲氧基丙氧基)苯 | CAS号1029324-91-1 (4S)-3,4-Dihydr... | CAS号1589-49-7 3-甲氧基-1-丙醇 | CAS号169250-16-2 magnesium,1-met... | CAS号172900-74-2 3-(3-甲氧基丙氧基)-4-... | CAS号172900-75-3 3-(3-甲氧基丙氧基)-4-... | CAS号173336-76-0 4-溴-1-甲氧基-2-(3-... | CAS号7008-00-6 二甲力嗪3-甲氧基-1-丙醇置于三溴化磷体系中,化学反应生成1-溴-3-甲氧基丙烷
参考文献:Npy Antagonists,Preparation And Uses
标题:Npy Antagonists,Preparation And Uses
摘要:本发明涉及新颖化合物,它们的制备和用途,特别是在治疗方面的用途.更具体地说,它涉及至少具有两个芳香环的衍生化合物,它们的制备和用途,特别是在人类或动物健康领域.这些化合物对存在于中枢和外周神经系统中的神经肽y(npy)的生物受体具有亲和力.本发明的化合物优选为npy拮抗剂,更具体地说是npy Y1亚型的拮抗剂,因此可用于治疗或预防涉及npy的任何疾病.本发明还涉及含有所述化合物的药物组合物,其制备和用途,以及使用所述化合物的治疗方法.
专利信息
专利号:WO-2011148392-A1
优先权日:2010-05-28
标题 :Process for the preparation of (2s,4s,5s,7s)-n-(2-carbamyl-2- methylpropyl)-5-amino-4-hydroxy-2,7-diisopropyl-8-[4-methoxy-3-(3- methoxypropoxy)phenyl]-octanamide hemifumarate and its intermediates thereof
发明人:SATYANARAYANA REDDY MANNE; THIRUMALAI RAJAN SRINIVASAN; ESWARAIAH SAJJA; VENKAT REDDY GHOJALA; RAMA SUBBA REDDY KARAMALA; SAHADEVA REDDY MARAMREDDY
权利人:MSN LAB LTD; SATYANARAYANA REDDY MANNE; THIRUMALAI RAJAN SRINIVASAN; ESWARAIAH SAJJA; VENKAT REDDY GHOJALA; RAMA SUBBA REDDY KARAMALA; SAHADEVA REDDY MARAMREDDY
摘要:The present invention relates to a process for the preparation of (2S,4S,5S,7S)-N-(2- Carbamoyl-2-methylpropyl)-5-amino-4-hydroxy-2,7-diisopropyl-8-[4-methoxy-3-(3-methoxy propoxy )phenyl]-octanamide compound of formula- 1 and its pharmaceutically acceptable salts thereof. Further, relates to the processes for the preparation of (R)-4-(2-(halomethyl)-3- methylbutyl)-l-methoxy-2-(3-methoxypropoxy) benzene and (R)-2-(4-methoxy-3-(3-methoxy propoxy) benzyl)-3-methyIbutan-l-ol useful intermediates in the synthesis of compound of formula- 1.
专利号:WO-2012078147-A1
优先权日:2010-12-08
标 题:A process for the preparation of intermediates useful in the production of aliskiren
发明人:BHANU MANJUNATH NARAYAN; NAIK SAMIR; THOMAS REJOY
权利人:WATSON LAB INC; BHANU MANJUNATH NARAYAN; NAIK SAMIR; THOMAS REJOY
摘要:A process for preparing 4-[(2R)-2-X-methyl)-3-methylbutyl]-1 -methoxy-2-3(3- methoxypropoxy)-benzene wherein X is a leaving group and use of this compound in the synthesis of aliskiren.
专利号:US-2011040105-A1
优先权日:2008-04-16
标题 :Processes useful for the synthesis of (r)-1--2-methyl-pyrrolidine
发明人:HUBER CHRISTIAN H; KHULMAN YOUNG MI; TANDEL SAGUN K; JOHANNSEN STEPHEN R; WANG TINGMIN; ANGELL PAUL
权利人:ARENA PHARM INC
摘要:Processes useful for making a pharmaceutically useful compound according to Formula (I), forms of such a compound, and intermediates useful in such processes are described.
专利号:US-5470973-A
优先权日:1994-10-03
标 题 :Synthesis of sulfonamide intermediates
发明人:HOFF ROMAN
权利人:ALCON LAB INC
摘要:Enantioselective syntheses of (S)-6-chloro-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazin-4-ol 1,1-dioxide and related compounds are described.
专利号:US-2014303333-A1
优先权日:2011-10-14
标题:Iron bisphenolate complexes and methods of use and synthesis thereof
发明人:SHAVER MICHAEL P; KOZAK CHRISTOPHER M
权利人:UNIV PRINCE EDWARD ISLAND; GENESIS GROUP INC
摘要:The present application, relates to iron bisphenolate complexes and methods of use and synthesis thereof. The iron complexes are prepared from tridentate or tetradentate ligands of Formula I: wherein R 1 and R 2 are as defined herein. Also provided are methods and processes of using the iron bisphenolate complexes as catalysts in cross-coupling reactions and in controlled radical polymerizations.
专利号:WO-2013084241-A1
优先权日:2011-12-09
标题:Compounds as inhibitors of renin
发明人:THOMBARE PRAVIN S; DESAI JIGAR N
权利人:CADILA HEALTHCARE LTD; THOMBARE PRAVIN S; DESAI JIGAR N
摘要:The present invention relates to novel renin inhibitors of general formula (1), novel intermediates involved in their synthesis, their pharmaceutically acceptable salts and pharmaceutical compositions containing them. The present invention also relates to processes for preparing compounds of general formula (1), their tautomeric forms, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, and novel intermediates involved in their synthesis.